Records containing: Multiparametric MRI
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-23Early Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen Response (PRODART)
-
CLINICAL_TRIALS study record update · 2025-09-02Reproducibility of Multiparametric Renal Magnetic Resonance Imaging on 1.5T MRI Scanners (RESPECT_1.5T Sub-study)
-
CLINICAL_TRIALS study record update · 2025-03-31The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targeted Biopsy. (PANDORA): a Prospective, Paired Diagnostic Study
-
CLINICAL_TRIALS study record update · 2023-04-19Deep Learning Super Resolution Reconstruction for Fast and Motion Robust T2-weighted Prostate MRI
-
CLINICAL_TRIALS study record update · 2022-02-24Use of Multiparametric Magnetic Resonance Imaging in the Management of Head and Neck Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-02-24Use of Multiparametric Magnetic Resonance Imaging in the Management of Head and Neck Cancer: a Prospective Analysis
-
CLINICAL_TRIALS study record update · 2021-10-28Clinical Utility of Vesical Imaging Report and Data System (VI-RADS) in Diagnosis of Muscle Invasive Bladder Cancer
-
CLINICAL_TRIALS study record update · 2017-10-19Multiparametric MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Cancer (MAVERICK)